Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.23%AUDUSD-1.17%GBPCHF+1.02%USDCHF+0.94%GBPNZD+0.79%GBPCAD+0.79%NZDUSD-0.75%USDCAD+0.73%AUDJPY-0.69%EURGBP-0.65%USDTHB+0.64%EURAUD+0.60%EURUSD-0.60%GBPJPY+0.57%USDJPY+0.51%AUDCAD-0.47%AUDNZD-0.43%GBPTRY+0.41%CHFJPY-0.40%PLNJPY+0.39%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%USDTRY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCHF-0.26%NZDJPY-0.22%CADCHF+0.22%CADJPY-0.21%NZDCHF+0.20%USDZAR+0.20%USDSEK+0.17%EURNZD+0.16%USDILS+0.16%USDMXN+0.14%USDCNH-0.14%USDNOK+0.13%EURCAD+0.13%EURZAR+0.13%GBPZAR+0.11%NZDSGD-0.11%EURSEK+0.11%CHFSEK+0.10%USDSGD+0.10%AUDNOK+0.10%EURJPY-0.09%NZDMXN-0.09%EURNOK+0.09%CHFNOK+0.08%EURHKD-0.07%GBPUSD+0.06%AUDSGD+0.06%USDDKK+0.05%EURSGD+0.04%USDCOP-0.04%USDPLN+0.04%CHFSGD+0.04%USDHKD+0.03%GBPSGD+0.02%EURPLN-0.02%NZDCAD-0.01%AUDDKK+0.01%EURCNH0.00%EURDKK0.00%EURCZK0.00%XAGUSD+0.70%GAGUSD+0.70%HG1-0.64%USOIL-0.49%UKOIL-0.33%S1-0.27%XPTUSD-0.25%COTTON-0.21%XNGUSD-0.08%GAUUSD-0.06%XAUUSD-0.06%C1+0.03%BTCUSD-0.19%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.07%ZECUSDT-0.02%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.57%XLMUSD+2.18%BCHUSDT-0.61%UNIUSD-0.74%LTCUSD+0.07%SUIUSD+1.70%HBARUSDT+1.75%TONUSD+15.77%TAOUSDT+0.27%AAVEUSD-2.45%DOTUSDT+2.87%ICPUSDT-1.58%ONDOUSDT+0.21%WLDUSDT+10.30%ARBUSDT-0.33%JUPUSDT-1.11%ATOMUSDT+1.34%INJUSDT-3.04%STXUSDT+18.01%FETUSDT+3.26%SEIUSDT+0.33%PYTHUSDT-3.04%TIAUSDT-0.07%IMXUSDT+0.97%GRTUSDT-0.44%OPUSDT-0.24%WIFUSDT+3.87%IOTAUSDT+4.03%POLUSDT-4.75%AXSUSDT+0.76%FARTCOINUSDT-0.30%EOSUSDT+4.07%DYDXUSDT+3.32%GALAUSDT+3.85%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.23%AUDUSD-1.17%GBPCHF+1.02%USDCHF+0.94%GBPNZD+0.79%GBPCAD+0.79%NZDUSD-0.75%USDCAD+0.73%AUDJPY-0.69%EURGBP-0.65%USDTHB+0.64%EURAUD+0.60%EURUSD-0.60%GBPJPY+0.57%USDJPY+0.51%AUDCAD-0.47%AUDNZD-0.43%GBPTRY+0.41%CHFJPY-0.40%PLNJPY+0.39%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%USDTRY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCHF-0.26%NZDJPY-0.22%CADCHF+0.22%CADJPY-0.21%NZDCHF+0.20%USDZAR+0.20%USDSEK+0.17%EURNZD+0.16%USDILS+0.16%USDMXN+0.14%USDCNH-0.14%USDNOK+0.13%EURCAD+0.13%EURZAR+0.13%GBPZAR+0.11%NZDSGD-0.11%EURSEK+0.11%CHFSEK+0.10%USDSGD+0.10%AUDNOK+0.10%EURJPY-0.09%NZDMXN-0.09%EURNOK+0.09%CHFNOK+0.08%EURHKD-0.07%GBPUSD+0.06%AUDSGD+0.06%USDDKK+0.05%EURSGD+0.04%USDCOP-0.04%USDPLN+0.04%CHFSGD+0.04%USDHKD+0.03%GBPSGD+0.02%EURPLN-0.02%NZDCAD-0.01%AUDDKK+0.01%EURCNH0.00%EURDKK0.00%EURCZK0.00%XAGUSD+0.70%GAGUSD+0.70%HG1-0.64%USOIL-0.49%UKOIL-0.33%S1-0.27%XPTUSD-0.25%COTTON-0.21%XNGUSD-0.08%GAUUSD-0.06%XAUUSD-0.06%C1+0.03%BTCUSD-0.19%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.07%ZECUSDT-0.02%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.57%XLMUSD+2.18%BCHUSDT-0.61%UNIUSD-0.74%LTCUSD+0.07%SUIUSD+1.70%HBARUSDT+1.75%TONUSD+15.77%TAOUSDT+0.27%AAVEUSD-2.45%DOTUSDT+2.87%ICPUSDT-1.58%ONDOUSDT+0.21%WLDUSDT+10.30%ARBUSDT-0.33%JUPUSDT-1.11%ATOMUSDT+1.34%INJUSDT-3.04%STXUSDT+18.01%FETUSDT+3.26%SEIUSDT+0.33%PYTHUSDT-3.04%TIAUSDT-0.07%IMXUSDT+0.97%GRTUSDT-0.44%OPUSDT-0.24%WIFUSDT+3.87%IOTAUSDT+4.03%POLUSDT-4.75%AXSUSDT+0.76%FARTCOINUSDT-0.30%EOSUSDT+4.07%DYDXUSDT+3.32%GALAUSDT+3.85%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%
RT

Relay Therapeutics, Inc. (RLAY)

NASDAQ • Healthcare

$18.05
-$0.3 (-1.7%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$18.45
Day Range$17.93 - $18.71
Avg. Volume (3M)3.5M
Market Cap$3.9B
52 Week Range
$5.17$21.27
Next EarningsIn 35 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$350K100%
Gross Profitminus cost of goods$350K100%

Fundamentals & Financials

Revenue (TTM)
$10.3M
Net Income (TTM)
-$286M
EPS (TTM)
-$1.57
ROA (TTM)
-29.57%
Current Ratio
18.27

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.8%Q1 2026-$0.32
-17.1%Q2 2026-$0.41
-4.8%Q3 2026-$0.41
Next

Nov 5

in 35 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -4.8%

Relay Therapeutics missed EPS expectations in the second fiscal quarter of 2026, reporting on Aug. 6 based on preliminary results, with a loss of $0.41 per share versus a $0.39 loss estimate, 4.8% below consensus. The company posted about $350,000 of gross profit, but operating income was a loss of $90.8 million and operating cash flow was negative $105.2 million. Net loss came in at about $83.7 million, widening 18.9% from roughly $70.4 million a year ago.

View full earnings history

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops small molecule therapies for cancer and genetic conditions through a precision-medicine approach and clinical trials. In FY2025, Relay Therapeutics generated $15.4 million in revenue. The company, formerly known as Allostery, Inc., is based in Cambridge, Massachusetts, was founded in 2015, and went public in 2020.

Name
Relay Therapeutics, Inc.
CEO
Sanjiv K. Patel
Website
www.relaytx.com
Industry
Healthcare
Year Founded
2015
Employees
202

Today's Snapshot

AI-generated

RLAY closed 1.7% below yesterday's close, in line with a weaker sector.

Trading Volume

Below 10d avg (3.9M)

2.7M

vs S&P 500 Today

Underperforming Market

-1.88%

Updated: September 30, 2026 at 20:26 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
RLAY displays short-term weakness against a backdrop of longer-term support as the stock trades near $18.05 with a subdued ADX that points to limited trend intensity. Momentum is tilted lower with a negative MACD and recent price action sitting below short- and intermediate moving averages, while the 100- and 200-day averages remain supportive, indicating a longer-term base. On-balance-volume readings suggest distribution pressure even as volatility is moderate, and the pivot lies close to the market, offering no clear breakout signal. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$14.10 - $18.58
    Sell
  • RSI (14)44.53
    Neutral
  • Stochastic %K (14, 3, 3)37.25
    Neutral
  • MACD Level (12, 26)-0.33
    Sell

Peers & Related Assets

AMLXAmylyx Pharmaceuticals, Inc.
$29.1-0.6%
ZBIOZenas BioPharma, Inc.
$26.97+0.8%
SNDXSyndax Pharmaceuticals, Inc.
$18.8+3.1%
INBXInhibrx Biosciences Inc.
$100.08-4.5%
ORICORIC Pharmaceuticals, Inc.
$13.47+0.8%
SANASana Biotechnology, Inc.
$2.92+0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.